Literature DB >> 9552414

The role of cyclin E in cell proliferation, development and cancer.

K Keyomarsi1, T W Herliczek.   

Abstract

Normal cell proliferation is under strict regulation governed by checkpoints located at distinct points in the cell cycle. The deregulation of these checkpoint events and the molecules associated with them may transform a normal cell into a cancer cell. One of these checkpoints whose deregulation results in transformation occurs at the Restriction point, near the G1/S boundary. The periodic appearance of one of the recently identified regulatory cyclins, cyclin E, coincides precisely with the timing of the Restriction point. The deregulation in the expression and activity of cyclin E has been associated with a number of cancers and is thought to be involved in the process of oncogenesis. In this chapter, we summarise the current knowledge on the regulation and apparent function of cyclin E in normal proliferating cells and in developing tissue and alterations of these processes in cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9552414     DOI: 10.1007/978-1-4615-5371-7_14

Source DB:  PubMed          Journal:  Prog Cell Cycle Res        ISSN: 1087-2957


  32 in total

1.  Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.

Authors:  E Santoni-Rugiu; J Falck; N Mailand; J Bartek; J Lukas
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex.

Authors:  L Le Cam; J Polanowska; E Fabbrizio; M Olivier; A Philips; E Ng Eaton; M Classon; Y Geng; C Sardet
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

3.  Cyclin E and chromosome instability in colorectal cancer cell lines.

Authors:  C Simone; N Resta; L Bagella; A Giordano; G Guanti
Journal:  Mol Pathol       Date:  2002-06

Review 4.  Posttranscriptional regulation of cancer traits by HuR.

Authors:  Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-06       Impact factor: 9.957

Review 5.  Cell cycle control mechanisms in B-1 and B-2 lymphoid subsets.

Authors:  Michael J Piatelli; Debra Tanguay; Thomas L Rothstein; Thomas C Chiles
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 6.  Ubiquitin, the centrosome, and chromosome segregation.

Authors:  Ying Zhang; Paul J Galardy
Journal:  Chromosome Res       Date:  2016-01       Impact factor: 5.239

7.  Calpain plays a central role in 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in cerebellar granule neurons.

Authors:  Richard A Harbison; Kristen R Ryan; Heather M Wilkins; Emily K Schroeder; F Alexandra Loucks; Ron J Bouchard; Daniel A Linseman
Journal:  Neurotox Res       Date:  2010-03-24       Impact factor: 3.911

8.  Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological significance.

Authors:  N Kato; J Watanabe; T Jobo; Y Nishimura; T Fujisawa; Y Kamata; H Kuramoto
Journal:  J Cancer Res Clin Oncol       Date:  2003-04-08       Impact factor: 4.553

9.  A novel interaction between HER2/neu and cyclin E in breast cancer.

Authors:  E A Mittendorf; Y Liu; S L Tucker; T McKenzie; N Qiao; S Akli; A Biernacka; Y Liu; L Meijer; K Keyomarsi; K K Hunt
Journal:  Oncogene       Date:  2010-05-10       Impact factor: 9.867

10.  Global microRNA characterization reveals that miR-103 is involved in IGF-1 stimulated mouse intestinal cell proliferation.

Authors:  Yalin Liao; Bo Lönnerdal
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.